Device / Technology News

RSS

NACHC, American College of Physicians announce program to offer Medical Home Builder 2.0

The American College of Physicians (ACP) and the National Association of Community Health Centers (NACHC) announced today a national effort to help federally-qualified health centers (FQHCs) improve care by offering ACP's Medical Home Builder 2.0 at a discounted rate.

29 Nov 2012

WellStar Health System implements Xenex’s room disinfection system

WellStar Health System was the first to implement and is the only health system in metro-Atlanta using Xenex Healthcare Services' room disinfection system in its patient and operating rooms. A "green," mercury-free technology, the Xenex system is the fastest, safest and most effective method for the advanced cleaning of hospital rooms, scientifically proven to destroy all major classes of microorganisms that cause hospital acquired infections (HAIs), such as MRSA and Clostridium difficile (C. diff).

29 Nov 2012

FDA approves Velomedix’s IDE to expand design of VELOCITY trial for heart attack

Velomedix, Inc., a venture-backed medical device company advancing the field of therapeutic hypothermia, announced it has received Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to expand the design of its VELOCITY pilot clinical trial.

29 Nov 2012

China's SFDA approves QIAGEN careHPV Test and instrument platform

QIAGEN N.V. today announced that China's State Food and Drug Administration (SFDA) has approved QIAGEN's careHPV Test and instrument platform.

From QIAGEN Manchester Limited 29 Nov 2012

NuFACE receives FDA clearance for Trinity Facial Toning Device

NuFACE is thrilled to announce the launch the FDA cleared Trinity Wrinkle Remover, a red light attachment for the NuFACE Trinity Facial Toning Device. The removable attachment is engineered with advanced LEDs to deliver a precise combination of red and infrared light therapy treatments to reduce full face wrinkles.

29 Nov 2012

Vermillion’s OVA1 diagnostic test effectively identifies early-stage ovarian cancer

Gynecologic Oncology, the prestigious medical journal of the Society for Gynecologic Oncology, has published the second prospective clinical study of OVA1 which demonstrated the positive performance of the multi-biomarker test in the triage of early-stage ovarian cancer.

29 Nov 2012

Macular pigment screener launched by Elektron Technology

Elektron Technology is launching a new, easy-to-use macular pigment screener (MPS II) that can quickly identify those most at risk of developing age-related macular degeneration (AMD).

28 Nov 2012

Chalmers researcher develops world's first implantable robotic arm controlled by thoughts

The world's first implantable robotic arm controlled by thoughts is being developed by Chalmers researcher Max Ortiz Catalan. The first operations on patients will take place this winter.

28 Nov 2012

Solvias, Hovione partner to develop and supply pharmaceutical co-crystals

Hovione and Solvias today announced the establishment of a collaboration focused on the development and GMP supply of pharmaceutical co-crystals. This strengthens Hovione's expertise and experience in overcoming drug delivery challenges and also the supply of GMP materials from phase I to commercial scale, with Solvias' excellence in solid state chemistry.

28 Nov 2012

Aviacode, NextGen partner to provide integrated cloud-delivered medical coding services

NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. and a leading provider of healthcare information systems and connectivity solutions, announced today it has partnered with Aviacode, the industry leader in technology-enabled medical coding services, to provide integrated cloud-delivered medical coding services to NextGen Healthcare clients.

28 Nov 2012

Trovagene develops first molecular diagnostic test to detect KRAS mutations from urine samples

Trovagene, Inc. today announced successful development of its first molecular diagnostic test capable of detecting KRAS mutations from a urine specimen. Transfer of the transrenal KRAS test to the company's CLIA lab is expected to be completed in December 2012 with commercial availability expected in January 2013.

28 Nov 2012

Hebrew University of Jerusalem develops sonar vision device for congenitally blind people

A "sonar vision" system that enables people who are blind from birth to perceive the shape of a face, a house or even words and letters, is being developed by a team at the Hebrew University of Jerusalem.

28 Nov 2012

Florbetapir PET scans can detect brain amyloid deposits associated with Alzheimer’s

A test to detect brain amyloid deposits associated with Alzheimer disease (AD) provides doctors with useful information on treatment and further testing for patients with cognitive impairment, according to a study published online by the journal Alzheimer Disease & Associated Disorders.

28 Nov 2012

Researchers aim to improve feeling of 'walking on marbles' for arthritis patients

Researchers at the University of Southampton are to undertake a new stage of a study aimed at improving the health and mobility of those suffering from the common complaint of 'walking on marbles' associated with Rheumatoid Arthritis (RA) in the feet.

28 Nov 2012

High-resolution real-time images show how nerves may be damaged during earliest stages of MS

High-resolution real-time images show in mice how nerves may be damaged during the earliest stages of multiple sclerosis. The results suggest that the critical step happens when fibrinogen, a blood-clotting protein, leaks into the central nervous system and activates immune cells called microglia.

28 Nov 2012

Investing in eyeglasses in developing nations could boost global economy, study shows

"Eliminating the worldwide shortage of eyeglasses could cost up to $28 billion, but would add more than $200 billion to the global economy, according to a study" conducted by researchers from Australia and the Johns Hopkins Bloomberg School of Public Health and published last month in the Bulletin of the World Health Organization, the New York Times reports.

28 Nov 2012

Microneedle-based measles vaccine can immunize against measles

Measles vaccine given with painless and easy-to-administer microneedle patches can immunize against measles at least as well as vaccine given with conventional hypodermic needles, according to research done by the Georgia Institute of Technology and the Centers for Disease Control and Prevention (CDC).

28 Nov 2012

Novo Nordisk launches HemaGo mobile app to help individuals with hemophilia

Novo Nordisk announced today the introduction of HemaGo, a mobile application (app) to help individuals with hemophilia and their caregivers monitor the details of treatment, including medications, dosing, bleed information and the impact of hemophilia on life events.

From Novo Nordisk 28 Nov 2012

Merrimack’s MM-302 Phase I results and MM-DX-929 preclinical data to be presented at SABCS

Merrimack Pharmaceuticals, Inc. today announced that Phase I data evaluating the novel agent MM-302 for the treatment of advanced HER2+ breast cancer and preclinical data on potential imaging and biomarker-based diagnostics will be presented at the 2012 CTRC-AACR San Antonio Breast Cancer Symposium (SABCS), Dec. 4-8, 2012 in San Antonio, Texas.

28 Nov 2012

THI to launch saliva-based TeloTest in first quarter 2013

Telome Health, Inc. (THI), developer of the TeloTest diagnostic test that measures average telomere length, announces the planned launch of the saliva-based TeloTest in the first quarter of 2013. Related telomere tests, including percentage of short telomeres, would follow.

28 Nov 2012

Device / Technology News

NACHC, American College of Physicians announce program to offer Medical Home Builder 2.0

WellStar Health System implements Xenex’s room disinfection system

FDA approves Velomedix’s IDE to expand design of VELOCITY trial for heart attack

China's SFDA approves QIAGEN careHPV Test and instrument platform

NuFACE receives FDA clearance for Trinity Facial Toning Device

Vermillion’s OVA1 diagnostic test effectively identifies early-stage ovarian cancer

Macular pigment screener launched by Elektron Technology

Chalmers researcher develops world's first implantable robotic arm controlled by thoughts

Solvias, Hovione partner to develop and supply pharmaceutical co-crystals

Aviacode, NextGen partner to provide integrated cloud-delivered medical coding services

Trovagene develops first molecular diagnostic test to detect KRAS mutations from urine samples

Hebrew University of Jerusalem develops sonar vision device for congenitally blind people

Florbetapir PET scans can detect brain amyloid deposits associated with Alzheimer’s

Researchers aim to improve feeling of 'walking on marbles' for arthritis patients

High-resolution real-time images show how nerves may be damaged during earliest stages of MS

Investing in eyeglasses in developing nations could boost global economy, study shows

Microneedle-based measles vaccine can immunize against measles

Novo Nordisk launches HemaGo mobile app to help individuals with hemophilia

Merrimack’s MM-302 Phase I results and MM-DX-929 preclinical data to be presented at SABCS

THI to launch saliva-based TeloTest in first quarter 2013

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News